Search results

Altasciences conducted two drug-drug interaction studies to evaluate a novel cardiovascular therapy’s safety with clopidogrel and warfarin, ensuring safe co-administration.

Discover FDA guidances for oligonucleotide bioanalysis, safety assessments, and clinical pharmacology, and how Altasciences supports regulatory-compliant drug development.

Discover 10 life science resources that you may have missed from Altasciences in 2024, including case studies, webinars, podcasts, posters, and videos!

Discover how Altasciences reduced clinical trial start-up timelines by 70%, initiating the first dose of a Phase I MAD study in just 3.5 weeks.

Explore Canada `s advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.